Atrix Laboratories to Present at the Tucker Anthony Sutro Life Science and Health Care Conference - April 5, 2001 Webcast -

Apr 02, 2001, 01:00 ET from Atrix Laboratories, Inc.

    FORT COLLINS, Colo., April 2 /PRNewswire/ -- Atrix Laboratories, Inc.
 (Nasdaq: ATRX) today announced that it has been invited to present at the
 fourth annual Tucker Anthony Sutro Life Science and Health Care Conference to
 be held in Laguna Niguel, California on Thursday, April 5, 2001.  Atrix will
 present at 6:00 p.m. EST.  The presentation will be accessible through a link
 posted on the Atrix website home page at www.atrixlabs.com.
 
     About Atrix Laboratories Inc.
     Atrix Laboratories, Inc. is an emerging specialty pharmaceutical company
 focused on advanced drug delivery.  With five unique patented technologies,
 Atrix is currently developing a diverse portfolio of proprietary products,
 including oncology, pain management, and dermatology products.  The company
 also partners with large pharmaceutical and biotechnology companies to apply
 its proprietary technologies to new chemical entities or to extend the patent
 life of existing products.  Atrix has strategic alliances with several
 pharmaceutical companies including recent collaborations with Pfizer, Elan
 Corporation Plc, Sanofi-Synthelabo and the Novartis company -- Geneva
 Pharmaceuticals, to use its drug delivery technologies and expertise in the
 development of new products.  Additional information is available on the Atrix
 Laboratories, Inc. Web site at http://www.atrixlabs.com.
 
     Statements contained in this press release, which are not historical
 facts, are forward-looking statements, as the term is defined in the Private
 Securities Litigation Reform Act of 1995.  Such forward-looking statements are
 subject to risks and uncertainties which can cause actual results to differ
 materially from those currently anticipated, due to a number of factors, which
 include, but are not limited to, product demand, pricing, market acceptance,
 changing economic conditions, risks in product and technology development, the
 effect of the company's accounting policies and other risk factors discussed
 in documents filed by the company with the Securities and Exchange Commission
 from time to time.
 
 

SOURCE Atrix Laboratories, Inc.
    FORT COLLINS, Colo., April 2 /PRNewswire/ -- Atrix Laboratories, Inc.
 (Nasdaq: ATRX) today announced that it has been invited to present at the
 fourth annual Tucker Anthony Sutro Life Science and Health Care Conference to
 be held in Laguna Niguel, California on Thursday, April 5, 2001.  Atrix will
 present at 6:00 p.m. EST.  The presentation will be accessible through a link
 posted on the Atrix website home page at www.atrixlabs.com.
 
     About Atrix Laboratories Inc.
     Atrix Laboratories, Inc. is an emerging specialty pharmaceutical company
 focused on advanced drug delivery.  With five unique patented technologies,
 Atrix is currently developing a diverse portfolio of proprietary products,
 including oncology, pain management, and dermatology products.  The company
 also partners with large pharmaceutical and biotechnology companies to apply
 its proprietary technologies to new chemical entities or to extend the patent
 life of existing products.  Atrix has strategic alliances with several
 pharmaceutical companies including recent collaborations with Pfizer, Elan
 Corporation Plc, Sanofi-Synthelabo and the Novartis company -- Geneva
 Pharmaceuticals, to use its drug delivery technologies and expertise in the
 development of new products.  Additional information is available on the Atrix
 Laboratories, Inc. Web site at http://www.atrixlabs.com.
 
     Statements contained in this press release, which are not historical
 facts, are forward-looking statements, as the term is defined in the Private
 Securities Litigation Reform Act of 1995.  Such forward-looking statements are
 subject to risks and uncertainties which can cause actual results to differ
 materially from those currently anticipated, due to a number of factors, which
 include, but are not limited to, product demand, pricing, market acceptance,
 changing economic conditions, risks in product and technology development, the
 effect of the company's accounting policies and other risk factors discussed
 in documents filed by the company with the Securities and Exchange Commission
 from time to time.
 
 SOURCE  Atrix Laboratories, Inc.